{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hauppauge",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81458",
      "recalling_firm": "Sciegen Pharmaceuticals Inc",
      "address_1": "89 Arkay Dr",
      "address_2": "N/A",
      "postal_code": "11788-3727",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0270-2019",
      "product_description": "GSMS Irbesartan Tablets, USP, 75 mg, 30-count bottle, Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Marketed by: GSMS Incorporated Camarillo, CA 93012 USA, NDC 60429-640-90.",
      "product_quantity": "3,835 HDPE bottles",
      "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.",
      "recall_initiation_date": "20181029",
      "center_classification_date": "20181120",
      "termination_date": "20230925",
      "report_date": "20181128",
      "code_info": "60429-640-90 Irbesartan 75mg Tablets, 90 Count Bottle B160003 Sep-19   B160004 Sep-19",
      "more_code_info": ""
    }
  ]
}